ama

AMA Update 408: COVID surge 2024, Wegovy side effect study and using AI in medicine with Andrea Garcia, JD, MPH

An update on the surge of COVID and other respiratory diseases in the US and across the world. AMA’s Vice President of Science, Medicine and Public Health, Andrea Garcia, JD, MPH, discusses the JN.1 variant that’s driving this surge and explains how it compares to the Omicron surge. Plus, the latest prescription trends in weight-less drugs like Ozempic and whether or not Ozempic and Wegovy have a side effect of suicidal ideation. American Medical Association CXO Todd Unger hosts.

🦠 Looking for COVID vaccine news or wondering how to cure COVID? Get CDC COVID vaccine guidelines, the JN.1 variant COVID symptoms 2024, plus the latest on COVID medications and Paxlovid rebound, watch: https://youtu.be/Co6dQKxzSwQ?si=DswJoTa55uLwvQWG

💧 Wastewater COVID dashboard via CDC National Wastewater Surveillance System (NWSS): https://www.cdc.gov/nwss/index.html

💉 Searching for «COVID shots near me», «flu vaccine near me» or wondering «is it too late to get the flu shot»? It’s not! Find vaccines in your area at: https://www.vaccines.gov/find-vaccines/

📬 Free COVID tests by mail still available, USPS order free COVID test kits: https://www.covid.gov/tests

🧪 Check expired COVID test expiration date extensions here: https://www.fda.gov/medical-devices/coronavirus-covid-19-and-medical-devices/home-otc-covid-19-diagnostic-tests#list

🔬 Nature Medicine study «Association of semaglutide with risk of suicidal ideation in a real-world cohort»: https://www.nature.com/articles/s41591-023-02672-2

🩺 The AMA is your powerful ally in patient care. Join now: https://bit.ly/AMAJoinRenew

Read More

AMA Update 405: New COVID variant JN.1 symptoms, latest studies on Paxlovid rebound and Hydroxychloroquine

An in-depth look at the latest wave of respiratory infections sweeping the country. AMA’s Vice President of Science, Medicine and Public Health, Andrea Garcia, JD, MPH, discusses trends in COVID, flu and RSV infections, details of the latest COVID variant, and the return of mask mandates. Plus, the low use of Paxlovid and deaths linked to the use of hydroxychloroquine to treat COVID during the first wave of the pandemic. American Medical Association CXO Todd Unger hosts.

💧 Wastewater COVID dashboard via CDC National Wastewater Surveillance System (NWSS): https://www.cdc.gov/nwss/index.html

💉 Searching for «flu vaccine near me» or «cdc.gov vaccines»? Find vaccines in your area at: https://www.vaccines.gov/find-vaccines/

🗺️ CDC FluView Weekly US Map and Influenza Summary Update: https://www.cdc.gov/flu/weekly/usmap.htm

🦠 Free at home COVID tests by mail still available: https://www.covid.gov/tests

🧪 Check expired COVID test expiration date extensions here: https://www.fda.gov/medical-devices/coronavirus-covid-19-and-medical-devices/home-otc-covid-19-diagnostic-tests#list

💊 Learn more about the Home Test to Treat program: https://www.test2treat.org/

🔬 National Institutes of Health’s «Paxlovid (nirmatrelvir/ritonavir) effectiveness against hospitalization and death in N3C: A target trial emulation study»: https://pubmed.ncbi.nlm.nih.gov/37398261/

📈 Hydroxychloroquine study «Deaths induced by compassionate use of hydroxychloroquine during the first COVID-19 wave: an estimate» in Biomedicine & Pharmacotherapy journal: https://www.sciencedirect.com/science/article/pii/S075333222301853X

📊 Nature Communications study «Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials»: https://www.nature.com/articles/s41467-021-22446-z

🩺 The AMA is your powerful ally in patient care. Join now: https://bit.ly/AMAJoinRenew

Read More

AMA Update 402: Reforming Medicare payment, fixing prior authorization and more milestones in 2023

In the final AMA Update episode of 2023, American Medical Association CXO Todd Unger reflects on this year of rebuilding and the key accomplishments of the AMA Recovery Plan for America’s Physicians.

🥼 Learn more about the AMA Recovery Plan for America’s Physicians: https://bit.ly/AMA_RecoveryPlan

🩺 The AMA is your powerful ally in patient care. Join now: https://bit.ly/AMAJoinRenew

Read More

AMA Update 397: Program signaling tips and strategies for residency applications with Kathleen Kashima, PhD

The most common questions medical students have about preference signaling in residency applications—answered. Kathleen Kashima, PhD, senior associate dean of students, at University of Illinois College of Medicine provides an overview of residency program signaling and how students can best use it to stand out. American Medical Association CXO Todd Unger hosts.

🏫 Residency Programs Participating in Program Signaling: https://students-residents.aamc.org/applying-residencies-eras/residency-programs-participating-program-signaling

🥼 Specialties Participating in Program Signaling for the 2024 ERAS® Application Season: https://students-residents.aamc.org/applying-residencies-eras/myeras-application-and-program-signaling-2023-24#SpecialtiesParticipating

💻 2024 ERAS® Application Season Program Signaling: https://connect.aamc.org/resourcelibraries/2024erasprogramsignaling

🌐 AAMC MyERAS login: https://myeras.aamc.org/myeras-web/

🩺 The AMA is your powerful ally in patient care. Join now: https://bit.ly/AMAJoinRenew

Read More

AMA Update 396: Rising COVID cases, China pneumonia outbreak and free COVID treatment with Andrea Garcia, JD, MPH

The latest developments on respiratory virus season, including COVID and the flu. AMA’s Vice President of Science, Medicine and Public Health, Andrea Garcia, JD, MPH, discusses the latest case counts, tips to protect yourself, why the COVID vaccination rate is so low, and a new government program that provides free COVID testing and treatment. Plus, an overview of everything we know about the rise of respiratory illnesses, including pneumonia, in China and the US. American Medical Association CXO Todd Unger hosts.

💧 Wastewater COVID dashboard via CDC National Wastewater Surveillance System (NWSS): https://www.cdc.gov/nwss/index.html

💊 Learn more about the Home Test to Treat program: https://www.test2treat.org/

🦠 Free COVID tests by mail still available: https://www.covid.gov/tests

🩺 The AMA is your powerful ally in patient care. Join now: https://bit.ly/AMAJoinRenew

Read More

AMA Update 395: Federal legislation to lift the burden of prior authorization with Rep. Michael Burgess, MD

A new bill at the federal level, called the GOLD Card Act of 2023, has the potential to fix prior authorization. One of the co-sponsors of the bill, Michael Burgess, MD, Congressman (R-Texas), joins to discuss the GOLD Card Act and what the bill means for physicians and their patients. American Medical Association CXO Todd Unger hosts.

🗣 Get involved! Patients and physicians can share prior authorization stories at: https://fixpriorauth.org/

🏛️ Stay up to date on the AMA’s advocacy efforts to fix prior authorization: https://www.ama-assn.org/practice-management/prior-authorization/advocacy-action-fixing-prior-authorization

🩺 The AMA is your powerful ally in patient care. Join now: https://bit.ly/AMAJoinRenew

Read More

AMA Update 366: The importance of preparing medical students for residency with John Andrews, MD

John Andrews, MD, vice president of GME Innovations at the AMA, joins to discuss the transition from undergraduate medical education to graduate medical education and how to prepare medical students for residency. Dr. Andrews points out the biggest pain points in the transition and the things incoming residents can do between medical school and residency to prepare to practice.

💻 Get more information on AMA’s GME Competency Education Program (GCEP) at: https://bit.ly/AMAEdHub_GCEP

🎓 Access undergraduate medical education resources via AMA’s UME Curricular Enrichment Program, here: https://bit.ly/AMAEdHub_UME

🧠 For more on AMA’s work to accelerate change in medical education—or ChangeMedEd®️ Initiative, visit: https://bit.ly/AMA_ChangeMedEd

🩺 The AMA is your powerful ally in patient care. Join now: https://bit.ly/AMAJoinRenew

Read More

AMA Update 355: Getting Rid of Stupid Stuff to make your private practice more efficient with Sea Chen, MD, PhD

The challenges that private practice physicians face and solutions from the American Medical Association. Sea Chen, MD, physician director of the Practice Sustainability Group at the AMA, discusses how the AMA is helping independent physicians with burnout, practice management and improvement, and learning the business skills to start and grow their practice. AMA CXO Todd Unger hosts.

🔑 Access AMA Private Practice Simple Solutions and more free resources for physicians, here: https://www.ama-assn.org/practice-management/private-practices/ama-private-practice-simple-solutions

🆓 Download AMA’s «Private Practice Playbook: Sample Forms»: https://www.ama-assn.org/practice-management/ama-steps-forward/private-practice-playbook-sample-forms

🎙 Listen to «Private Practice: Attending to Business» podcast episodes on AMA Ed Hub™: https://edhub.ama-assn.org/steps-forward/pages/podcast-private-practice-attending-to-business

🥼 Learn more about the AMA Recovery Plan for America’s Physicians: https://bit.ly/AMA_RecoveryPlan

🩺 The AMA is your powerful ally in patient care. Join now: https://bit.ly/AMAJoinRenew

Read More

AMA Update 339: New FDA-approved RSV shot for babies and CDC’s ACIP meeting recap with Sandra Fryhofer, MD

The CDC’s Advisory Committee on Immunization Practices (ACIP) recommended a new monoclonal antibody shot that can protect babies from RSV. The AMA’s ACIP liaison, Sandra Fryhofer, MD, joins to discuss the recommendation and details of the shot, including who should get it, how often and what the side effects are. American Medical Association CXO Todd Unger hosts.

🩺 The AMA is your powerful ally in patient care. Join now: https://bit.ly/AMAJoinRenew

Read More

AMA Update 317: RSV vaccine recommendations and ACIP meeting recap with Sandra Fryhofer, MD

Who should get vaccinated for RSV? What are the side effects and safety concerns for RSV vaccines? Your vaccine questions answered by Sandra Fryhofer, MD — the AMA ACIP liaison and AMA’s immediate past board chair. Dr. Fryhofer shares everything physicians need to know about the new recommendations from CDC’s Advisory Committee on Immunization Practices (ACIP) for both #RSV vaccines. American Medical Association CXO Todd Unger hosts.

Read More